Kazuhiro Daimon

Title: Kazuhiro Daimon: Innovator in Vaccine Development

Introduction

Kazuhiro Daimon is a notable inventor based in Kikuchi, Japan. He has made significant contributions to the field of vaccine development, particularly with his innovative approach to combined vaccine formulations. His work is essential in enhancing public health through effective immunization strategies.

Latest Patents

Kazuhiro Daimon holds a patent for a liquid six combined vaccine composition. This formulation includes DPT-IPV-Hib-HBs, where a hepatitis B surface (HBs) antigen is stably adsorbed to an aluminum adjuvant. The patent outlines a method for producing a stable liquid formulation that effectively combines vaccines against diphtheria, pertussis, tetanus, polio, type b (Hib), and hepatitis B (HepB). The detailed steps in the patent ensure the stability and efficacy of the vaccine, which is crucial for its success in immunization programs.

Career Highlights

Kazuhiro Daimon is associated with Km Biologics Co., Ltd., where he continues to work on innovative vaccine solutions. His expertise in vaccine formulation has positioned him as a key player in the biotechnology sector. His contributions are vital in addressing public health challenges through advanced immunization techniques.

Collaborations

Kazuhiro collaborates with talented professionals in his field, including Kanae Ishikawa and Haruna Iwata. These collaborations enhance the research and development efforts at Km Biologics Co., Ltd., fostering innovation in vaccine technology.

Conclusion

Kazuhiro Daimon's work in vaccine development exemplifies the importance of innovation in public health. His patented liquid six combined vaccine composition represents a significant advancement in immunization strategies. Through his career and collaborations, he continues to make a lasting impact on the field of biotechnology.